| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $9.8M | +3.5% |
| SG&A Expense | $10.2M | +63.9% |
| Operating Income | -$19.9M | -27.4% |
| Interest Expense | $901K | +3455.0% |
| Pre-tax Income | -$22.4M | -44.4% |
| Net Income | -$22.4M | -44.4% |
| EPS (Basic) | -$4.44 | +56.5% |
| EPS (Diluted) | -$4.44 | +56.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.0M | -10.3% |
| Current Assets | $12.0M | -5.2% |
| Total Assets | $15.1M | +1.4% |
| Current Liabilities | $10.3M | +107.4% |
| Total Liabilities | $12.6M | +69.6% |
| Stockholders' Equity | $2.5M | -66.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.2M | +6.5% |
| Capital Expenditures | $162K | -23.4% |
| Investing Cash Flow | -$162K | +23.4% |
| Financing Cash Flow | $16.1M | -47.6% |
| Free Cash Flow | -$17.4M | +6.7% |